Determining how differentiation and survival of different subsets of memory CD4+ T cells in autoimmune disease conditions are affected by factors such as cytokine milieu and the presence of autoantigens may lead to potential new avenues for treatment of disease progression and relapses. This evidence concerns the gene CD4 and autoimmune disease.